CPT1C and neoplasm: More recently, Chen et al. reported that miR-1291 targets estrogen-related receptor alpha (ERRα) to inhibit the expression level of carnitine palmitoyltransferase 1C (CPT1C), causing a decrease in cell proliferation in vitro and tumor growth in vivo [41].